HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Toroso Investments LLC

Toroso Investments LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 6.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,170 shares of the company’s stock after purchasing an additional 561 shares during the period. Toroso Investments LLC’s holdings in HCA Healthcare were worth $2,298,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. GoalVest Advisory LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $26,000. Wolff Wiese Magana LLC increased its holdings in shares of HCA Healthcare by 1,833.3% in the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock worth $29,000 after acquiring an additional 110 shares during the period. San Luis Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the 1st quarter worth about $35,000. Covestor Ltd increased its holdings in shares of HCA Healthcare by 122.7% in the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after acquiring an additional 92 shares during the period. Finally, Riverview Trust Co bought a new position in HCA Healthcare in the 1st quarter valued at about $45,000. 65.75% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Loop Capital initiated coverage on shares of HCA Healthcare in a research report on Thursday, June 16th. They set a “buy” rating and a $240.00 price objective for the company. Stephens increased their price target on shares of HCA Healthcare to $230.00 in a research report on Monday, July 25th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Oppenheimer set a $255.00 price objective on shares of HCA Healthcare in a research report on Monday, June 20th. Finally, Citigroup dropped their price target on shares of HCA Healthcare from $254.00 to $240.00 in a research report on Tuesday, July 26th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $237.71.

Insider Activity at HCA Healthcare

In related news, major shareholder Patricia F. Elcan acquired 325 shares of the business’s stock in a transaction dated Monday, July 25th. The stock was bought at an average price of $198.66 per share, with a total value of $64,564.50. Following the acquisition, the insider now owns 89,337 shares in the company, valued at approximately $17,747,688.42. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is owned by insiders.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $208.97 on Friday. The stock has a 50-day simple moving average of $201.80 and a 200 day simple moving average of $217.21. The company has a quick ratio of 1.32, a current ratio of 1.55 and a debt-to-equity ratio of 87.46. HCA Healthcare, Inc. has a 12-month low of $164.47 and a 12-month high of $279.02. The stock has a market capitalization of $59.98 billion, a price-to-earnings ratio of 10.05, a P/E/G ratio of 1.61 and a beta of 1.72.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings results on Friday, July 22nd. The company reported $4.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.54. The business had revenue of $14.82 billion during the quarter, compared to analysts’ expectations of $14.73 billion. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $4.37 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 17.1 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Friday, September 16th will be given a $0.56 dividend. The ex-dividend date is Thursday, September 15th. This represents a $2.24 annualized dividend and a dividend yield of 1.07%. HCA Healthcare’s dividend payout ratio is presently 10.77%.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.